Skip to main content

Low-dose segmental blockade of the nephron rather than high-dose diuretic monotherapy

European Journal of Clinical Pharmacology volume 44, pages S63–S68 (1993)Cite this article

Summary

The specific renal effect of diuretics is due to the fact that their concentrations is almost 100-fold greater in the renal tubule than in the plasma.

The function of the different segments of the nephron may be altered following changes in the effective arterial blood volume (EABV) and the extracellular fluid volume (ECFV). In diseases with reduced EABV, e.g., congestive heart failure, decompensated cirrhosis of the liver, and the nephrotic syndrome, proximal tubular hyperreabsorption of sodium occurs, leaving only a low Na+ load in the distal segments of the nephron, the site of diuretic action. Clinically, the response to diuretics is reduced or resistance to diuretics may even ensue, which can be predicted by a FENa < 0.2%. Resistance to diuretics can be overcome by short-term comedication with acetazolamide, which increases Na+ delivery to the site of action of the other diuretics used concomitantly.

In states with increased ECFV e.g. in chronic renal failure, there is distal tubular Na+ rejection, leading to a greater increase in FENa the more GFR is reduced. The remaining intact nephrons present a relatively increased response to diuretics. The efficacy of diuretic treatment in renal failure can be optimised by combining loop diuretics with thiazides.

In conclusion, low-dose combination therapy, inducing “segmental blockade of the nephron”, meets the functional changes along the nephron. It is therefore more effective and safer than high-dose monotherapy.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Brater DC, Anderson SA, Brown-Cartwright D (1986) Response to furosemide in chronic renal insufficiency: Rational for limited dose. Clin Pharmacol Ther 40:134–139

    PubMed  Google Scholar 

  2. Brater DC, Chennavasin P, Seiwell R (1980) Furosemide in patients with heart failure: Shift in dose-response curves. Clin Pharmacol Ther 28 (2) 182–186

    PubMed  Google Scholar 

  3. Bricker NS, Fine LG, Kaplan MA, Epstein M, Burgoignie JJ, Licht A (1978) “Magnification phenomenon” in chronic renal disease. N Engl J Med 299:1287–1293

    PubMed  Google Scholar 

  4. Eknoyan G (1990) Abnormal sodium and chloride balance, 7. Diagnosis of disturbances In: Seldin DW, Giebisch G (eds) The regulation of sodium and chloride balance. Raven Press, New York, pp 237–259

    Google Scholar 

  5. Epstein M, Lepp BA, Hoffmann DS, Levinson R (1977) Potentiation of furosemide by metolazone in refractory edema. Curr Therap Res 21:656–667

    Google Scholar 

  6. Gerber JG (1981) Antihypertensive agents and diuretics. In: Anderson RJ, Schrier RW (eds) Clinical use of drugs in patients with kidney and liver disease. Saunders London, pp 211–229

    Google Scholar 

  7. Hasenfuß G, Holubarsch C, Herzog C, Knauf H, Spahn H, Mutschler E, Just H (1987) Influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide. Clin Cardiol 10:83–88

    PubMed  Google Scholar 

  8. Hropot M, Fowler N, Kalmark B, Giebisch G (1985) Tubular actions of diuretics: distal effects on electrolyte transport and acidification. Kidney Int 28:477–489

    PubMed  Google Scholar 

  9. Keller E, Hoppe-Seyler G, Mumm R, Schollmeyer P (1981) Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide. Eur J Clin Pharmacol 20:27–33

    PubMed  Google Scholar 

  10. Keller E, Hoppe-Seyler G, Schollmeyer P (1982) Disposition and diuretic effect of furosemide in the nephrotic syndrome. Clin Pharmacol Ther 32:442–449

    PubMed  Google Scholar 

  11. Knauf H, Just HJ (1984) Neuere Entwicklungen auf dem Gebiet der diuretischen Therapie der Herzinsuffizienz. Therapiewoche 34:2449–2460

    Google Scholar 

  12. Knauf H, Mutschler E (1984) Pharmacodynamics and pharmacokinetics of xipamide in patients with normal and impaired kidney function. Eur J Clin Pharmacol 26:513–520

    PubMed  Google Scholar 

  13. Knauf H, Mutschler E (1989) The Na load in the nephron segment determines the ceiling quality of a diuretic. In: Puschett JB, Greenberg A (eds) Diuretics III, chemistry, pharmacology, and clinical applications. Elsevier, Amsterdam New York, London, pp 359–362

    Google Scholar 

  14. Knauf H, Mutschler E (1990) Saluretic effects of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion. Eur J Clin Pharmacol 39:337–343

    PubMed  Google Scholar 

  15. 15.Knauf H, Mutschler E (1992) Constant K+/Na+excretion ratio by piretanide during peak diuresis, but insignificant K+ loss during 24 hours. Eur J Clin Pharmacol 43:23–27

    PubMed  Google Scholar 

  16. Knauf H, Mutschler E (1991) Pharmacodynamic and kinetik considerations on diuretics as a basis for differential therapy. Klin Wochenschr 69:239–250

    PubMed  Google Scholar 

  17. Knauf H, Reuter K, Mutschler E (1985) Limitation on the use of amiloride in early renal failure. Eur J Clin Pharmacol 28:61–66

    PubMed  Google Scholar 

  18. Knauf H, Wenk E, Schölmerich J, Goerg KJ, Gerok W, Leser HG, Mutschler E (1990) Prediction of diuretic mobilization of cirrhotic ascites by pretreatment fractional sodium excretion. Min Wochenschr 68:545–551

    Google Scholar 

  19. Oster JR, Epstein M, Smoller S (1983) Combined therapy with thiazide-type and loop diuretic agents for resistant sodium retention. Ann Intern Med 99:405–406

    PubMed  Google Scholar 

  20. Spahn H, Knauf H, Mutschler E (1990) Pharmacokinetics of torasemide and its metabolites in healthy controls and in chronic renal failure. Eur J Clin Pharmacol 39:345–348

    PubMed  Google Scholar 

  21. Rupp W, Heidland A, Hajdú P, Neuhaus G (1971) Pharmakokinetik von Furosemid bei normaler und eingeschränkter Nierenfunktion. In: Kluthe R (ed) Medikamentöse Therapie bei Nierenerkrankungen. Thieme, Stuttgart, pp 207–213

    Google Scholar 

  22. Scheler F (1969) Anwendung von Saluretika bei Niereninsuffizienz. In: Krück F, Leppla W (eds) Klinische Pharmakologie der Diuretika. Urban & Schwarzenberg, München Berlin Wien, pp 83–92

    Google Scholar 

  23. Sigurd B, Olesen KH, Wennevold A (1975) The supra-additive natriuretic effect of addition of bendroflumethiazide and bumetanide in congestive heart failure. Am Heart J 89:163–170

    PubMed  Google Scholar 

  24. Skorecki KL, Brenner BM (1982) Body fluid homeostasis in congestive heart failure and cirrhosis with ascites. Am J Med 72:323–338

    PubMed  Google Scholar 

  25. Slatopolsky E, Elken I, Weerts C, Bricker NS (1968) Studies on the characteristics of the control system governing sodium excretion in uremic man. J Clin Invest 47:521–530

    PubMed  Google Scholar 

  26. Schrier RW (1988) Pathogenesis of sodium and water retention in high and low output cardiac failure, cirrhosis, nephrotic syndrome, and pregnancy. N Engl J Med 319:1065–1072

    PubMed  Google Scholar 

  27. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J (1988) Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8:1151–1157

    PubMed  Google Scholar 

  28. Wollam GL, Tarazi RC, Bravo EL, Dustan HP (1982) Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. Am J Med 72:929–938

    PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Medizinische Klinik I, St. Bernward-Krankenhaus Treibestrasse 9, W-3200, Hildesheim, Germany

    H. Knauf & E. Mutschler

Authors
  1. H. Knauf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Mutschler
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

The paper is dedicated to my clinical teacher of medicine, Prof. Dr. W. Gerok, who helped me to adapt basic research to clinical practice.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Knauf, H., Mutschler, E. Low-dose segmental blockade of the nephron rather than high-dose diuretic monotherapy. Eur J Clin Pharmacol 44, S63–S68 (1993). https://doi.org/10.1007/BF01428397

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01428397

Key words

  • Renal failure
  • Diuretics
  • low dose drug combinations
  • segmental nephron blockade